The role of osteoclasts and tumour-associated macrophages in osteosarcoma metastasis

被引:91
|
作者
Endo-Munoz, Liliana [1 ]
Evdokiou, Andreas [2 ]
Saunders, Nicholas A. [1 ]
机构
[1] Univ Queensland, Diamantina Inst, Brisbane, Qld 4102, Australia
[2] Univ Adelaide, Queen Elizabeth Hosp, Basil Hetzel Inst, Adelaide, SA 5005, Australia
来源
关键词
Osteosarcoma; Metastasis; Osteoclast; Tumour-associated macrophage; Microenvironment; ENCAPSULATED MURAMYL TRIPEPTIDE; BONE-RESORBING CELLS; FACTOR-KAPPA-B; ZOLEDRONIC ACID; BREAST-CANCER; PULMONARY METASTASES; GENE-EXPRESSION; IN-VITRO; OSTEOPROTEGERIN LIGAND; PEDIATRIC OSTEOSARCOMA;
D O I
10.1016/j.bbcan.2012.07.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Osteosarcoma (OS) is the most common primary bone tumour in the paediatric age group. Treatment-refractory pulmonary metastasis continues to be the major complication of OS, reducing the 5-year survival rate for these patients to 10-20%. The mechanisms underlying the metastatic process in OS are still unclear, but undoubtedly, a greater understanding of the factors and interactions involved in its regulation will open new and much needed opportunities for therapeutic intervention. Recent published data have identified a new role for bone-specific macrophages (osteoclasts) and tumour-associated macrophages (TAMs), in OS metastasis. In this review we discuss the contribution of TAMs and osteoclasts in the establishment and maintenance of secondary metastatic lesions, and their novel role in the prevention of metastatic disease in a primary bone cancer such as osteosarcoma. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:434 / 442
页数:9
相关论文
共 50 条
  • [1] The role of tumour-associated macrophages in bone metastasis
    Sousa, Sofia
    Maatta, Jorma
    [J]. JOURNAL OF BONE ONCOLOGY, 2016, 5 (03): : 135 - 138
  • [2] Tumour-associated macrophages in metastasis-associated osteolysis
    Athanasou, NA
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 : P17 - P17
  • [3] Dasatinib is a potent inhibitor of tumour-associated macrophages, osteoclasts and the FMS receptor
    N Brownlow
    C Mol
    C Hayford
    S Ghaem-Maghami
    N J Dibb
    [J]. Leukemia, 2009, 23 : 590 - 594
  • [4] Dasatinib is a potent inhibitor of tumour-associated macrophages, osteoclasts and the FMS receptor
    Brownlow, N.
    Mol, C.
    Hayford, C.
    Ghaem-Maghami, S.
    Dibb, N. J.
    [J]. LEUKEMIA, 2009, 23 (03) : 590 - 594
  • [5] The role of tumour-associated macrophages in tumour angiogenesis and metastasis: regulation by hypoxia and angiopoietin-2
    Lewis, C. E.
    [J]. EJC SUPPLEMENTS, 2007, 5 (04): : 16 - 16
  • [6] Targeting tumour-associated macrophages
    Sica, Antonio
    Rubino, Luca
    Mancino, Alessandra
    Larghi, Paola
    Porta, Chiara
    Rimoldi, Monica
    Solinas, Graziella
    Locati, Massimo
    Allavena, Paola
    Mantovani, Alberto
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2007, 11 (09) : 1219 - 1229
  • [7] Tumour-associated macrophages and cancer
    Cook, Jenny
    Hagemann, Thorsten
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2013, 13 (04) : 595 - 601
  • [8] The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies
    Bingle, L
    Brown, NJ
    Lewis, CE
    [J]. JOURNAL OF PATHOLOGY, 2002, 196 (03): : 254 - 265
  • [9] Clinical relevance of tumour-associated macrophages
    Pittet, Mikael J.
    Michielin, Olivier
    Migliorini, Denis
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2022, 19 (06) : 402 - 421
  • [10] Clinical relevance of tumour-associated macrophages
    Mikael J. Pittet
    Olivier Michielin
    Denis Migliorini
    [J]. Nature Reviews Clinical Oncology, 2022, 19 : 402 - 421